Patrick Campbell

New data indicates a combination of 3 natural extracts added to standard therapy could provide benefits in patients with uncontrolled hypertension.

An analysis of the French cohort from the TST trial was presented during ISC 2020 in Los Angeles, CA.

Research from the Karolinska Institute indicates ESC/EAS 2019 dyslipidemia guidelines could create an unforeseen financial burden due to new eligibility for PSCK9 class.

Macrolide use during the first trimester was linked to an increase in major malformations—specifically cardiovascular malformations—in children.

A fourth-year medical student keeps a log of the sessions he attends and his perspective on information from the SCCM's 49th Annual Critical Care Congress.

A new analysis is revealing more about how using a patient portal can aid in medication adherence and HbA1c management among diabetics.

New data on the use of polygenic risk scores for predicting certain forms of cardiovascular disease raise questions about the validity of genetic scores in real-world settings.

Analysis using data from the Nurses' Health Study is shedding new light on the interaction of TMAO and coronary heart disease risk.

A new study from the Columbia University Irving Medical Center found another diuretic appeared to have less serious side effects than the guideline-recommended chlorthalidone.

The FDA announced the switch of the 2 eyedrops, which took place through their RX-to-OTC program.

A study from Rutgers University is shedding more light on the additional cardiovascular risk among preeclamptic women.

Vitreoretinal surgeon discusses what ophthalmologists would need to see from a new treatment to replace aflibercept as first-line treatment for wet AMD.

A pilot study found consumption of cocoa and epicatechin were linked to improved six-minute walking time in PAD patients.

A review of trials from more than 100 cancer drugs found almost 40% did not report any cardiovascular disease outcomes.

Analysis of the CAMELLIA-TIMI 61 trial revealed patients receiving the weight-loss add-on had an increased risk of cancer.

Data from the TAUSSIG study supports the long-term use of evolocumab for the treatment of both phenotypes of hypercholesterolemia.

Data from a randomized trial finds subconcussive head impacts are linked to visual dysfunction for up to 24 hours.

New research from the American Stroke Association's International Stroke Conference indicates the presence of diabetic retinopathy was associated with increased stroke risk.

Older patients with no stroke history are shown to have reduced risk for both shingles and stroke in new CDC data.

A new study sheds light on the impact of statins and metformin use on risk of death in prostate cancer patients.

Results of a phase 2 trial from Oculis S.A. support use of their novel eye drop formulation for the treatment of diabetic macular edema.

Inovoio Pharmaceuticals will assess INO-3107 to eventually become the first drug indicated for the rare disease.

David Lee, MD, of NYU School of Medicine, discusses barbershop initiatives and how they can impact the health care of a community as a whole.

Discussing how the approval of brolucizumab in late 2019 impacts current treatment algorithms for wet age-related macular degeneration.

An analysis of the MESA study is shedding light on the potential association between having persistent asthma and developing atrial fibrillation.

New study using data obtained through wearables found resting heart rate can vary by up to 70 beats per minute from patient to patient.

New Penn Medicine data break down the impact each missed visit can have on treatment outcomes for patients with AMD.

A study of more than 300,000 older patients found use of tramadol was associated with an increased risk of hip fracture compared to 5 other pain medications.

A cardiologist and professor of medicine at Duke discusses the nuances of approaching stroke prevention in obese patients compared to those with other risk factors.

The CATALYST trial will examine use of the Amplatzer Amulet Left Atrial Appendage Occluder in more than 2500 patients with AFib at risk of stroke.